❭ Research by medical division ❭ Laboratory Medicine ❭ Immunology ❭ Molecular immunology and vaccine development (Braathen) ❭ In the media ❭
  • Search
  • Publication search
  • Print page

In the media

Blog: Vaksinebloggen

Podcast: Vaksinepodden

 
Page visits: 274

Home Immunology Molecular immunology and vaccine development (Braathen)

  • Group members
  • Publications
  • In the media
  • Funding

Recent publications

Tesfaye DY, Bobic S, Lysén A, Huszthy PC, Gudjonsson A, Braathen R, Bogen B, Fossum E (2022)
Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection
Front Immunol, 13, 752714
DOI 10.3389/fimmu.2022.752714, PubMed 35296089

Bekri S, Rodney-Sandy R, Gruenstein D, Mei A, Bogen B, Castle J, Levey D, Cho HJ (2022)
Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens
J Immunother Cancer, 10 (2)
DOI 10.1136/jitc-2021-003572, PubMed 35190376

Lysén A, Gudjonsson A, Tesfaye DY, Bobic S, Bern M, Bogen B, Fossum E (2021)
Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection
Scand J Immunol, 95 (3), e13128
DOI 10.1111/sji.13128, PubMed 34923667

More publications

Get in touch

Ranveig Braathen
Institute of Immunology, Rikshospitalet, Oslo University Hospital
Sognsvannsveien 20, Section A2. 2nd. floor, Room:  A3.2006, 0372 Oslo, Norway
Phone: + 47 23 07 35 08, Cell: + 47 99732296, Fax: + 47 23 07 35 10
Email: Ranveig.braathen@medisin.uio.no, Ranveig.braathen@rr-research.no, ranvbr@ous-hf.no

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy